Pre-Exposure Prophylaxis in YMSM

NCT01033942 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP
DRUG: Placebo
BEHAVIORAL: Many Men, Many Voices (3MV)

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]
[object Object]